DURHAM, N.C., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Dance Biopharm Holdings, Inc., a clinical-stage company reimagining the treatment of chronic diseases with inhaled therapies, today presented data from its Phase 2 clinical study of Dance 501, a novel gentle mist formulation of human insulin administered with its smart inhaler, in patients with type 2 diabetes (T2D). The data were presented at the55th Annual Meeting of the European Association for the Study of Diabetes on September 19, 2019, in Barcelona, Spain. Study results showed Dance 501 inhaled human insulin (INH) had comparable glucodynamic properties to injected insulin lispro (LIS), but delivered a faster onset of action.
These encouraging study results demonstrate the potential of Dance 501 INH to offer a clinically meaningful benefit over rapid-acting insulin injections for patients with type 2 diabetes, while also providing a more comfortable patient experience, said Melissa Rhodes, Ph.D., chief development officer of Dance Biopharm. This study also further validates our smart inhalers ability to deliver an optimal and precise dose of inhaled therapies through the lungs. A number of diseases could benefit from the frequent pulsatile administration afforded by an inhaled delivery option, so we are exploring inhaled therapies beyond human insulin where our platform could achieve better treatment efficiency.
Dance 501 inhaled human insulin demonstrated faster onset and greater action in the first hour of administration compared to subcutaneous insulin lispro, with good tolerability in patients with type 2 diabetes, said Eric Zijlstra, Ph.D., lead study author and presenter. Not only does this allow for Dance 501 INH to be administered shortly before meals, but the ease of use could potentially motivate more patients to better comply with standard medical guidance.
Trial Design and Results
The randomized, controlled clinical study evaluated the pharmacodynamic action and safety of Dance 501 inhaled human insulin in comparison to injected insulin lispro in T2D patients. The study enrolled 24 subjects with type 2 diabetes on daily insulin therapy. Each patient received three doses 12, 24 and 48 U of Dance 501 (assuming a 13% relative biopotency) and subcutaneous insulin lispro. Patients received a total of six doses, administered over six visit that occurred 3 to 17 days apart. Insulin action was measured using the automated glucose clamp method over a 10-hour period following dosing.
Key findings from the clinical trial:
About Dance Biopharm
Dance Biopharm is a clinical-stage company reimagining the treatment of chronic diseases with inhaled therapies. Our gentle mist inhaler is designed with smart technology to optimize the precise delivery of biologic therapies through the lungs. We are building a diverse pipeline of inhaled biologic products with initial focus on rare and severe diseases in the endocrinology, respiratory and cardiovascular space, where our platform and expertise present a unique opportunity to achieve better treatment efficiency. We have initiated development programs in glucagon-like peptide-1 (GLP-1), parathyroid hormone (PTH) and human growth hormone (HGH).For more information, visit: https://www.dancebiopharm.com.
Investor Contact:Jeremy FefferLifeSci Advisors, LLC(212) 915-2568jeremy@lifesciadvisors.com
Media Contact:Gloria GasaaturaLifeSci Public Relationsggasaatura@lifescipublicrelations.com
Read the original here:
- Cost of Human Growth Hormone Therapy injections from ... - December 20th, 2018 [December 20th, 2018]
- HGH Injections - Information and Dosages - December 20th, 2018 [December 20th, 2018]
- HGH Injections Where To Get HGH Injections Online - December 20th, 2018 [December 20th, 2018]
- Where and how to buy HGH Injections Online from Wellness ... - December 28th, 2018 [December 21st, 2018]
- HGH Injections | Nutropin AQ (somatropin) injection, for ... - December 26th, 2018 [December 26th, 2018]
- Don't Take HGH Injections Until You Read This ... - January 21st, 2019 [January 21st, 2019]
- Buy Somatropin & Human Growth Hormone (HGH) Online Sale - April 8th, 2019 [April 8th, 2019]
- HGH Found to Promote Recovery from Spinal Damage - Gilmore Health News - October 14th, 2019 [October 14th, 2019]
- Human Growth Hormone Proven to Boost Ability to Sprint in Athletes - Gilmore Health News - October 14th, 2019 [October 14th, 2019]
- Aerami Therapeutics to Present Clinical Data on Dance 501 Inhaled Human Insulin at the 19th Diabetes Technology Meeting - BioSpace - November 14th, 2019 [November 14th, 2019]
- Everything You Need to Know about HGH Therapy in 2020 - ChartAttack - March 6th, 2020 [March 6th, 2020]
- Growth Hormone Benefits: Should You Take HGH Injections to Build Muscles and Lose Weight? - Globe Stats - March 6th, 2020 [March 6th, 2020]
- HGH Injections for Sale for Men & Women | Injectable HGH ... - March 9th, 2020 [March 9th, 2020]
- Growth hormone injections: Uses and side effects - March 9th, 2020 [March 9th, 2020]
- Growth hormone therapy: Who can benefit from HGH - Augusta Free Press - May 21st, 2020 [May 21st, 2020]
- Anti-Aging: HGH Can Reduce Biological Age by One Year and a Half Study Shows - Gilmore Health News - May 29th, 2020 [May 29th, 2020]
- Norditropin: The facts about this Prescription HGH Brand - Gilmore Health News - June 30th, 2020 [June 30th, 2020]
- HGH: Side Effects in Men and Women - Healthline - December 20th, 2020 [December 20th, 2020]
- Best HGH Injections On The Market | Top 5 HGH Brands in 2020 - December 20th, 2020 [December 20th, 2020]
- HCG vs HGH: Which Hormone Therapy Is Right for You? - seattlepi.com - March 11th, 2021 [March 11th, 2021]
- CrazyBulk Reviews 2022: How Good Is the Legal Steroids Brand? - Cleveland Scene - December 17th, 2021 [December 17th, 2021]
- Does HGH have anti-aging properties? - Medical News Today - June 16th, 2022 [June 16th, 2022]
- HGH Benefits: A Complete Guide to Its Positive Effects on the Body and the Mind - Gilmore Health News - December 6th, 2023 [December 6th, 2023]